Li Guangshuo, Kang Kaijiang, Ju Yi, Du Yang, Wang Anxin, Zhang Xiaoli, Xiong Yunyun, Zhao Xingquan, Wang Wenjuan
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
CNS Neurosci Ther. 2025 Jun;31(6):e70458. doi: 10.1111/cns.70458.
Surgical treatment has been shown to decrease mortality in patients with intracerebral hemorrhage (ICH) but has not consistently improved functional outcomes. This study aimed to investigate whether surgical treatment could enhance functional outcomes in ICH patients with a National Institutes of Health Stroke Scale (NIHSS) score of 10 or higher.
This multicenter study included patients from a registry cohort in China with supratentorial ICH, NIHSS scores of 10 or higher, and hematoma sizes of 25 mL or more. Patients were divided into surgical and medical treatment groups. The primary outcome was a modified Rankin Scale (mRS) score of 0-3 at 1 year.
A total of 429 patients were analyzed. The median NIHSS score at admission was 22 [15-29], and the ICH volume was 50 [35.28-72.9] ml. The surgical group had a higher proportion of mRS scores of 0-3 at 1 year compared to the medical group (49.68% vs. 38.32%, p = 0.022). Both craniotomy and minimally invasive surgery improved functional outcomes at 1 year (mRS 0-3, craniotomy: OR 2.324, 95% CI 1.266-4.267, p = 0.007; minimally invasive surgery: OR 4.884, 95% CI 1.914-12.445, p = 0.001).
For patients with supratentorial ICH, NIHSS scores of 10 or higher, and hematoma sizes of 25 mL or more, surgical treatment improved functional outcomes at 1 year compared to medical treatment. The specific subgroup of ICH patients that could benefit from surgical intervention remains controversial.
手术治疗已被证明可降低脑出血(ICH)患者的死亡率,但并未始终改善功能结局。本研究旨在调查手术治疗是否能改善美国国立卫生研究院卒中量表(NIHSS)评分在10分及以上的ICH患者的功能结局。
这项多中心研究纳入了来自中国一个注册队列的幕上ICH患者,NIHSS评分在10分及以上,血肿体积在25毫升及以上。患者被分为手术治疗组和药物治疗组。主要结局是1年时改良Rankin量表(mRS)评分为0 - 3分。
共分析了429例患者。入院时NIHSS评分中位数为22[15 - 29],ICH体积为50[35.28 - 72.9]毫升。与药物治疗组相比,手术治疗组在1年时mRS评分为0 - 3分的比例更高(49.68%对38.32%,p = 0.022)。开颅手术和微创手术均改善了1年时的功能结局(mRS 0 - 3,开颅手术:OR 2.324,95%CI 1.266 - 4.267,p = 0.007;微创手术:OR 4.884,95%CI 1.914 - 12.445,p = 0.001)。
对于幕上ICH、NIHSS评分在10分及以上且血肿体积在25毫升及以上的患者,与药物治疗相比,手术治疗在1年时改善了功能结局。能从手术干预中获益的ICH患者具体亚组仍存在争议。